Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
48.15
+1.16 (+2.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,371,947
Open
46.99
Bid (Size)
48.00 (100)
Ask (Size)
48.68 (1,500)
Prev. Close
46.99
Today's Range
46.86 - 48.62
52wk Range
44.12 - 78.48
Shares Outstanding
78,935,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead?
↗
July 20, 2026
Beam Therapeutics' growing pipeline could reward patient investors.
Via
The Motley Fool
3 Reasons to Buy CRISPR Therapeutics Stock
↗
July 10, 2026
The company's innovative qualities may pay rich dividends down the road.
Via
The Motley Fool
Performance
YTD
-10.5%
-10.5%
1 Month
-11.4%
-11.4%
3 Month
-16.5%
-16.5%
6 Month
-8.5%
-8.5%
1 Year
-26.3%
-26.3%
More News
Read More
Vertex’s Crinetics Deal Balances Growth with Integration Risk
↗
July 08, 2026
Via
MarketBeat
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics
↗
July 08, 2026
Via
The Motley Fool
Over 2 Billion Reasons to Love CRISPR Therapeutics Right Now
↗
July 07, 2026
Via
The Motley Fool
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?
↗
July 07, 2026
Via
The Motley Fool
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
↗
July 06, 2026
Via
The Motley Fool
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
↗
June 27, 2026
Via
The Motley Fool
The Best Stocks to Invest $1,000 in Right Now
↗
June 22, 2026
Via
The Motley Fool
Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This Year
↗
June 18, 2026
Via
The Motley Fool
The Best Biotech Stocks to Buy in 2026
↗
June 17, 2026
Via
The Motley Fool
Topics
ETFs
Here's How I'd Invest $10,000 Right Now
↗
June 17, 2026
Via
The Motley Fool
CRISPR Therapeutics Has $2.4 Billion in Cash and an Approved Drug. Why Is Its Stock Trading Nearly 40% Below the Wall Street Consensus?
↗
June 08, 2026
Via
The Motley Fool
CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential
↗
June 03, 2026
Via
The Motley Fool
Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out
↗
June 03, 2026
Via
The Motley Fool
CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking
↗
June 01, 2026
Via
The Motley Fool
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
↗
May 31, 2026
Via
The Motley Fool
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
↗
May 25, 2026
Via
The Motley Fool
The Best Stocks to Invest $3,000 In Right Now
↗
May 19, 2026
Via
The Motley Fool
CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms
↗
May 15, 2026
Via
MarketBeat
Topics
Intellectual Property
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
↗
May 11, 2026
Via
The Motley Fool
Is This Millionaire-Maker Biotech Stock a Buy Right Now?
↗
May 06, 2026
Via
The Motley Fool
Topics
Initial Public Offering
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering
↗
April 30, 2026
Via
The Motley Fool
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
↗
April 30, 2026
Via
The Motley Fool
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
↗
April 30, 2026
Via
The Motley Fool
Frequently Asked Questions
Is CRISPR Therapeutics AG - Common Shares publicly traded?
Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.
What exchange does CRISPR Therapeutics AG - Common Shares trade on?
CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?
The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market
What is the current price of CRISPR Therapeutics AG - Common Shares?
The current price of CRISPR Therapeutics AG - Common Shares is 48.15
When was CRISPR Therapeutics AG - Common Shares last traded?
The last trade of CRISPR Therapeutics AG - Common Shares was at 07/21/26 04:00 PM ET
What is the market capitalization of CRISPR Therapeutics AG - Common Shares?
The market capitalization of CRISPR Therapeutics AG - Common Shares is 3.80B
How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?
CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today